First-line afatinib for advanced EGFRm+ NSCLC: Analysis of long-term responders in the LUX-Lung 3, 6, and 7 trials
Titel:
First-line afatinib for advanced EGFRm+ NSCLC: Analysis of long-term responders in the LUX-Lung 3, 6, and 7 trials
Auteur:
Schuler, Martin Paz-Ares, Luis Sequist, Lecia V. Hirsh, Vera Lee, Ki Hyeong Wu, Yi-Long Lu, Shun Zhou, Caicun Feng, Jifeng Ellis, Stuart H. Samuelsen, Carl H. Tang, Wenbo Märten, Angela Ehrnrooth, Eva Park, Keunchil Yang, James Chih-Hsin